DoW Arthritis Translational Research Award
This grant funds high-impact, hypothesis-driven preclinical or animal research to accelerate arthritis findings into clinically relevant solutions for Service Members, Veterans, their families, and the public.
Funder: Dept. of the Army -- USAMRAA
Due Dates: July 22, 2026: Pre-Application (Preproposal) | October 22, 2026: Full Application | October 27, 2026: Application Verification
Funding Amounts: ~$1.6M total; up to $800,000 total costs per award (max 3 years); approx. 2 awards expected
Summary: Supports high-impact, translational, preclinical/animal research to accelerate findings into clinically relevant solutions for any type of arthritis.
Key Information: Clinical research/trials and basic research are not allowed; preliminary/published data required.
Description
This opportunity supports translational research projects that accelerate critical findings into clinically relevant solutions for arthritis. The program seeks hypothesis-driven, high-impact applied research relevant to Service Members, Veterans, their Families, and the general public. Research addressing any and all types of arthritis—including osteoarthritis, post-traumatic arthritis, inflammatory arthritis, juvenile arthritis, and rheumatoid arthritis—is encouraged. Projects must be preclinical or animal research only; basic research and clinical trials are specifically excluded.
The intent is to fund research that meaningfully advances the field and bridges the gap between discovery and clinical application, with a strong emphasis on impact and the potential to improve patient care and military health outcomes.
